INTEGRATED BIOPHARMA INC (INBP)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch INBP
See up to 3 months of INBP. The 7-day demo opens the 1M and 3M ranges and puts INBP on your watchlist.
Start 7-day demoLatest INBP insider trades
About INTEGRATED BIOPHARMA INC (INBP)
The SEC lists INTEGRATED BIOPHARMA INC under CIK 0001016504, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
INBP Form 4 activity by transaction type, last 90 days
No Form 4 activity for INBP in the last 90 days.
INBP insider transactions (Form 4)
3925 Form 4 filings on record, the earliest from Nov 25, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Damon Desantis - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Eric J. Friedman - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Robert Canarick - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| William H. Milmoe - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| William H. Milmoe - Director | Gift | Common Stock | 8,966,547 | $0.00 | - | |
| William H. Milmoe - Director | Gift | Common Stock | 2,235,417 | $0.00 | - | |
 Carl Desantis - 10% Owner | Gift | Common Stock | 8,966,547 | $0.00 | - | |
| Carl Desantis - 10% Owner | Gift | Common Stock | 2,235,417 | $0.00 | - | |
| Damon Desantis - Director | Gift | Common Stock | 8,966,547 | $0.00 | - | |
| Damon Desantis - Director | Gift | Common Stock | 2,235,417 | $0.00 | - | |
| Carl Desantis - 10% Owner | Gift | Common Stock | 1,356,293 footnote F1 | $0.00 | - | |
| Carl Desantis - 10% Owner | Gift | Common Stock | 7,392 footnote F3 | $0.00 | - | |
| ||||||
| William H. Milmoe - Director | Gift | Common Stock | 1,356,293 footnote F1 | $0.00 | - | |
| William H. Milmoe - Director | Gift | Common Stock | 7,392 footnote F3 | $0.00 | - | |
| ||||||
| Damon Desantis - Director | Gift | Common Stock | 1,356,293 | $0.00 | - | |
| Damon Desantis - Director | Gift | Common Stock | 7,392 | $0.00 | - | |
| Damon Desantis - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Eric J. Friedman - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| William H. Milmoe - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Robert Canarick - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| William H. Milmoe - Director | Grant or award | Common Stock | 50,000 | $0.09 | $5K | |
| William H. Milmoe - Director | Derivative | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Sheppard Riva - Officer | Grant or award | Common Stock | 144,445 | $0.09 | $13K | |
| Sheppard Riva - Officer | Derivative | Stock Option (Right to Buy) | 144,445 | $0.00 | - | |
| Christina Kay - Officer | Grant or award | Common Stock | 144,445 | $0.09 | $13K | |
| Christina Kay - Officer | Derivative | Stock Option (right to buy) | 144,445 | $0.00 | - | |
| Dina Masi - Officer | Grant or award | Common Stock | 135,000 | $0.09 | $12K | |
| Dina Masi - Officer | Derivative | Stock Option (right to buy) | 135,000 | $0.00 | - | |
| Robert Canarick - Director | Grant or award | Common Stock | 175,000 | $0.09 | $16K | |
| Robert Canarick - Director | Derivative | Stock Option (Right to Buy) | 175,000 | $0.00 | - | |
| Dina Masi - Officer | Grant or award | Stock Option (right to buy) | 125,000 | $0.00 | - | |
| Christina Kay - Officer | Grant or award | Stock Option (right to buy) | 125,000 | $0.00 | - | |
| Sheppard Riva - Officer | Grant or award | Stock Option (Right to Buy) | 125,000 | $0.00 | - | |
| Christina Kay - Officer | Grant or award | Common Stock | 55,555 | $0.09 | $5K | |
| Christina Kay - Officer | Derivative | Stock Option (right to buy) | 55,555 | $0.00 | - | |
| Dina Masi - Officer | Grant or award | Common Stock | 65,000 | $0.09 | $6K | |
| Dina Masi - Officer | Derivative | Stock Option (right to buy) | 65,000 | $0.00 | - | |
| Sheppard Riva - Officer | Grant or award | Common Stock | 55,555 | $0.09 | $5K | |
| Sheppard Riva - Officer | Derivative | Stock Option (Right to Buy) | 55,555 | $0.00 | - | |
Item 2.02, 9.01
Item 8.01
Item 1.01, 1.02, 9.01
Item 2.02, 9.01
INBP insider trading FAQ
What is the latest insider trade for INBP?
INTEGRATED BIOPHARMA INC (INBP) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-25. The full record for INBP runs to 25 Form 4 filings, the earliest from 2024-11-25. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INBP stock?
No insider purchases of INBP were filed in the last 90 days.
How many insiders are selling INBP stock?
No insider sales of INBP were filed in the last 90 days.
Where can I see INBP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INBP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Damon Desantis view on EDGAR
- - Eric J. Friedman view on EDGAR
- - Robert Canarick view on EDGAR
- - William H. Milmoe view on EDGAR
- - William H. Milmoe view on EDGAR
- - Carl Desantis view on EDGAR
- - Damon Desantis view on EDGAR
- - Carl Desantis view on EDGAR
- - William H. Milmoe view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where INBP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INBP with a 7-day demo
- INBP on your watchlist
- Every INBP Form 4 filing on record
- Up to 3 months of INBP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
